Clinical impact of medication reviews with follow-up in cardiovascular older adult patients
Year: 2020
Type: dissertation
Abstract: 𝗕𝗮𝗰𝗸𝗴𝗿𝗼𝘂𝗻𝗱: In Chile, cardiovascular disease (CVD) risk factors are controlled in as few as 30% of cases. Pharmacist-led medication reviews with follow up (MRF) have shown effectiveness under these conditions. We postulate that providing MRF in primary care in Chile could improve the control of CVD. \n𝗢𝗯𝗷𝗲𝗰𝘁𝗶𝘃𝗲𝘀: To evaluate the effect of MRF on CVD in primary care by assessing the clinical effect of MRF on older patients with CVD risk in primary care in Chile. \n𝗠𝗲𝘁𝗵𝗼𝗱𝗼𝗹𝗼𝗴𝘆: A systematic literature search was conducted to explore literature on the effect of MR on ambulatory CVD risk patients, including randomised and cluster randomised trials (c-RCT). Meta-analyses used the odds ratio (OR) for therapeutic goals and raw differences for continuous data, with 95% prediction intervals (PI) to account for heterogeneity. \nA c-RCT was then conducted in primary care centres in a metropolitan region of Chile. Older patients with moderate to high CVD risk and five or more medications were recruited from a CVD risk program and received either pharmacist-led MRF or usual care for a year. Generalised estimating equations adjusted for covariates were used for analysis during each visit. A sub-analysis of patients with chronic kidney disease (CKD) was conducted. \n𝗥𝗲𝘀𝘂𝗹𝘁𝘀: The meta-analyses included 69 studies with a total of 11 644 patients. Demographic characteristics were similar between studies. MRF increased the control of hypertension (OR 2.73 [95% PI 1.05, 7.08]), type 2 diabetes mellitus (OR 3.11 [95% PI 1.17, 5.88]) and cholesterol (OR 1.91 [95% PI 1.05, 3.46]). \nIn the Polaris trial, 324 patients from 12 primary care centres (174 in the MRF group and 150 in the usual care group, 6 centres each) received, on average, four visits by pharmacists in one year. Significant effects were found for the control of hypertension (OR 4.37 [2.54–7.51]), cholesterol (OR 3.67 [2.13–6.33]), type 2 diabetes (6.97 [3.69–13.2]) and medication adherence (OR 6.60 [1.36–31.9]) as well as for the number of medications (-0.86 [-1.14 to -0.58]) and CVD risk (-2.27 [-2.84 to -1.69]). In total, 159 patients had CKD (71 in the usual care group and 88 in the MRF group). The OR for hypertension control was 8.41 (3.46–20.4), with reductions in systolic blood pressure (-15.3 mmHg [-20.3 to -10.3]), serum potassium (-0.50 mEq/L [-0.65 to -0.35]), the albumin-to-creatinine ratio (-53.1 mg/g [-92.3 to -13.9]) and LDL cholesterol (-27.8 mg/dL [-37.6 to -17.9]). \n𝗖𝗼𝗻𝗰𝗹𝘂𝘀𝗶𝗼𝗻: This work provides local evidence to support the implementation of MRF in primary care in Chile. Including pharmacists in programs for CVD could improve the quality of care for older adults with polypharmacy.
Author: Francisco Martínez‐Mardones
Institution: University of Technology Sydney
Language: English
Subfield: Geriatrics and Gerontology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: University of Technology Sydney
OpenAlex ID: W3101883636
